Risk for Cardiovascular Conditions Increased With Anorexia Nervosa Diagnosis
By Elana Gotkine HealthDay Reporter
THURSDAY, Dec. 19, 2024 -- Patients with an anorexia nervosa (AN) diagnosis have an increased risk for cardiovascular conditions, according to a study published online Dec. 19 in JAMA Network Open.
Mei-Chih Meg Tseng, M.D., Ph.D., from Taipei Medical University in Taiwan, and colleagues examined the trajectories of cardiovascular condition risk in a nationwide cohort of patients with AN in Taiwan. Patients with AN and controls were identified through propensity score matching at a 1:10 ratio; the study population included 2,081 patients and 20,810 controls.
The researchers found that 4.8 and 0.8 percent of patients with AN and controls, respectively, had a major adverse cardiovascular event (MACE) and 6.0 versus 2.3 percent had any cardiovascular condition. The cumulative incidence rates of MACE and any cardiovascular condition were 4.82 and 6.19 percent, respectively, at the five-year follow-up. The AN group had significantly higher risks for MACE and any cardiovascular condition compared with the control group (adjusted hazard ratios, 3.78 and 1.93, respectively). In the initial follow-up period, there were significantly increased risks for congenital heart failure, conduction disorder, and structural heart disease, which disappeared after 60 months of follow-up. The risk for ischemic heart disease was only increased after 60 months of follow-up (adjusted hazard ratio, 3.01).
"Clinicians should monitor comorbid cardiovascular conditions in patients with AN in different stages of treatment," the authors write. "The underlying mechanisms for the intermediate-term outcome of ischemic heart disease warrant further investigation."
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2025 HealthDay. All rights reserved.
Posted December 2024
Read this next
Live Zoster Vaccination Linked to Lower Risk for Cardiovascular Events
THURSDAY, May 8, 2025 -- Live zoster vaccination is associated with a lower risk for overall cardiovascular events when compared with no vaccination, according to a study...
Real-Time AI-Driven Decision Support Aids Catheter Ablation
WEDNESDAY, May 7, 2025 -- An artificial intelligence (AI)-driven model can significantly improve procedural safety in cardiac electrophysiology with real-time decision support...
Di-2-ethylhexylphthalate Contributes to 13 Percent of All Cardiovascular Deaths in Those Aged 55 to 64
TUESDAY, May 6, 2025 -- Di-2-ethylhexylphthalate (DEHP) contributes to 13.497 percent of all cardiovascular deaths among individuals aged 55 to 64 years, with considerable...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.